Skip to main content

InvestorNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Appoints Former Navy SEAL Robert J. O’Neill to Advisory Board

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Nutriband (NASDAQ: NTRB) announced the appointment of Robert J. O’Neill to its Advisory Board. O’Neill served 16 years in the U.S. Navy, including eight years with the Naval Special Warfare Development Group (SEAL Team Six), and participated in more than 400 combat missions. He is also a New York Times best-selling author and advocate for expanding veterans access to emerging health treatments.

O’Neill will support Nutriband’s executive team on strategy, growth and execution as the company advances its pipeline of abuse-deterrent transdermal products, including AVERSA (TM) Fentanyl. The company said AVERSA Fentanyl would be the world’s first and only abuse-deterrent fentanyl patch if approved.

To view the full press release, visit https://ibn.fm/WuoNR

About Nutriband Inc.

We are primarily engaged in the development of a portfolio of transdermal pharmaceutical products. Our lead product under development is an abuse-deterrent fentanyl patch incorporating our AVERSA(TM) abuse-deterrent technology. AVERSA(TM) technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential.

The Company’s website is www.nutriband.com . Any material contained in or derived from the Company’s websites or any other website is not part of this press release.

NOTE TO INVESTORS: The latest news and updates relating to NTRB are available in the company’s newsroom at https://ibn.fm/NTRB

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Austin, Texas
www.InvestorWire.com
512.354.7000 Office
Editor@InvestorWire.com

InvestorWire is powered by IBN

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  250.40
+1.02 (0.41%)
AAPL  339.68
+3.76 (1.12%)
AMD  630.58
+1.32 (0.21%)
BAC  56.51
+0.48 (0.85%)
GOOG  340.57
+1.56 (0.46%)
META  750.78
-26.81 (-3.45%)
MSFT  516.62
+18.69 (3.75%)
NVDA  225.12
+0.54 (0.24%)
ORCL  138.14
-1.40 (-1.00%)
TSLA  372.15
-5.79 (-1.53%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.